Antiviral drug resistance increases hepatocellular carcinoma: A prospective decompensated cirrhosis cohort study
Author(s) -
Lei Li
Publication year - 2013
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v19.i45.8373
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , cirrhosis , prospective cohort study , hepatitis b , incidence (geometry) , cumulative incidence , antiviral therapy , hepatitis c , drug resistance , cohort , combination therapy , chronic hepatitis , immunology , virus , physics , optics , microbiology and biotechnology , biology
To study the clinical outcome of antiviral therapy in hepatitis B-related decompensated cirrhotic patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom